Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Molecular Therapy2010Vol. 18(4), pp. 843–851
Citations Over TimeTop 1% of 2010 papers
Richard A. Morgan, James C. Yang, Mio Kitano, Mark E. Dudley, Carolyn M. Laurençot, Steven A. Rosenberg
Related Papers
- Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.(2003)
- → Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System(2022)23 cited
- → Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)(2021)13 cited
- → Analysis of lumateperone data for patients with schizophrenia using related adverse events from the FDA adverse reporting system(2024)1 cited
- → Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024(2024)